超选择性眼动脉溶栓治疗视网膜中央动脉栓塞临床研究  

Comparative Clinical Study of Super-selective Ophthalmic Arterial Thrombolysis for Central Retinal Artery Occlusion

作　　者：赵均峰[1] 孙正伟[1] 李闯[1] 潘德旺 张宪坤[1] 李志国[1] 郑扬[1] 

机构地区：[1]吉林省四平市中心人民医院神经介入科,136000

出　　处：《心脑血管病防治》2017年第3期175-178,共4页CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT

摘　　要：目的探讨超选择性眼动脉(OA)溶栓治疗视网膜中央动脉阻塞(CRAO)的疗效及安全性。方法回顾性选择我院30例视网膜中央动脉阻塞患者作为研究对象,根据治疗方法分为超选择性OA溶栓组10例、静脉溶栓组10例和常规药物治疗组10例,比较分析各组治疗的效果。结果超选择性OA溶栓组总有效率显著高于对照组(P<0.05),差异有统计学意义。结论早期应用超选择性OA溶栓治疗可以一定程度提高CRAO患者的治疗效果,较其他治疗方法更有效。Objective To investigate the efficacy and safety of super-selective Ophthalmic arterial（OA） thrombolysis for central retinal artery occlusion （CRAO）. Methods 30 cases of CRAO patients in our hospital from January 2014 to December 2015 were retrospec- tively selected as the research objects. In order to compare and analyze the curative effects, these patients were divided into super-se- lective OA thrombolysis group （ 10 cases）, intravenous thrombolysis group （ 10 cases） and routine drug group （ 10 cases） according to the methods of treatment. Results The total effective rate of the super-selective OA thrombolysis group was significantly higher than that of the control groups （ P 〈 0.05）. Conclusions Early application of super-selective OA thrombolytic therapy can improve the cu- rative effect of CRAO in a certain degree, and thus is more effective than other treatments.

关 键 词：视网膜中央动脉栓塞 微导管 超选择性眼动脉溶栓 尿激酶 

分 类 号：R774.1[医药卫生—眼科]